Vistas | |
---|---|
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial | 185 |
noviembre 2024 | diciembre 2024 | enero 2025 | febrero 2025 | marzo 2025 | abril 2025 | mayo 2025 | |
---|---|---|---|---|---|---|---|
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial | 2 | 9 | 4 | 13 | 11 | 33 | 1 |
Vistas |
---|
Vistas |
---|